Skip to main content
Equibles

Polar Capital Holdings Plc

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1837309 London, X0
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$34,847,675
+$9,572,776 QoQ
Shares Held
5,117,133
-9.5% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#14
of 208 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. TSHA ranks #33 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELVN
Enliven Therapeutics, Inc.
 6,430,636 $326,354,777
2 XENE
Xenon Pharmaceuticals Inc.
 4,570,556 $275,878,760
3 CYTK
Cytokinetics Inc
 2,253,649 $191,988,358
4 RYTM
Rhythm Pharmaceuticals, Inc.
 1,663,632 $184,713,060
5 ARQT
Arcutis Biotherapeutics, Inc.
 6,606,945 $173,234,097
6 ASND
Ascendis Pharma A/S
 616,908 $164,541,701
7 BBIO
BridgeBio Pharma, Inc.
 2,063,609 $153,697,598
8 ALNY
Alnylam Pharmaceuticals, Inc.
 482,751 $145,322,533

All Filings in TSHA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,847,675 5,117,133
2026-03-31 $25,274,899 5,654,340
2025-12-31 $43,622,716 7,931,403
2025-09-30 $17,310,984 5,293,879
2025-06-30 $11,550,000 5,000,000
2025-03-31 $4,170,000 3,000,000
2024-12-31 $5,190,000 3,000,000
2024-09-30 $6,080,250 3,025,000
2024-06-30 $6,776,000 3,025,000
2024-03-31 $7,229,268 2,518,909
2023-12-31 $4,458,468 2,518,909
2023-09-30 $7,994,800 2,530,000